The Omnipod DASH is also covered by Medicare Part D, and it’s the only insulin pump currently covered by Medicare for those with type 2 diabetes who use insulin. Get started on Omnipod DASH ...

The Omnipod 5, which had been under FDA review since last year, is a hybrid, closed-loop insulin delivery system, meaning its insulin pump communicates directly with a user's continuous glucose ...

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

Come next month, Hollingshead will be taking over a company that topped $1 billion in annual revenue last year—a first in its two-decade history, with nearly the entire total tied to Omnipod ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its groundbreaking Omnipod ...

Insulet insulin pump Cybersecurity data breach The devicemaker notified affected users and filed a report of the breach with the U.S. Department of Health and Human Services on Jan. 5.

Insulet Omnipod 5 insulin pump bests conventional delivery systems. Mar. 08, 2024 8:43 AM ET Insulet Corporation (PODD) Stock MDT, DXCM, TNDM By: Dulan Lokuwithana, SA News Editor 4 Comments.

Insulet Corporation PODD reported Q3 sales of $432.7 million, up 27.0%, or 25.1% in constant currency, beating the consensus of $414.383 million. Total Omnipod revenue of $422 million marked a ...